We are live on ! Find out more
ASPX

AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX

Delisted

ASPX was delisted on the 4th of May, 2015.

Back to rankings

71 hedge funds and large institutions have $310M invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2014 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

278% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 9

111% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 9

56% more capital invested

Capital invested by funds: $198M → $310M (+$112M)

16% more funds holding

Funds holding: 61 → 71 (+10)

Holders
71
Holders Change
+10
Holders Change %
+16.39%
% of All Funds
2.06%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
19
Increased
34
Reduced
9
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$11.2M
2
Millennium Management
Millennium Management
New York
+$10.8M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.53M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.67M
5
WSA
Wall Street Associates
California
+$4.47M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.04M
2
DCM
Driehaus Capital Management
Illinois
-$1.05M
3
Morgan Stanley
Morgan Stanley
New York
-$836K
4
Jennison Associates
Jennison Associates
New York
-$425K
5
PP
PDT Partners
New York
-$399K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$67.2M +$5.53M +260,000 +11%
DM
2
Deerfield Management
New York
$64.5M +$11.2M +528,122 +27%
Millennium Management
3
Millennium Management
New York
$30M +$10.8M +505,894 +76%
Franklin Resources
4
Franklin Resources
California
$17.3M +$1.61M +75,750 +13%
Ameriprise
5
Ameriprise
Minnesota
$11.3M +$2.12M +99,418 +29%
WSA
6
Wall Street Associates
California
$11.2M +$4.47M +210,000 +93%
KCM
7
Kingdon Capital Management
New York
$10.9M +$2.55M +119,803 +39%
Vanguard Group
8
Vanguard Group
Pennsylvania
$9.31M +$4.67M +219,310 +153%
JP Morgan Chase
9
JP Morgan Chase
New York
$8.08M -$32.4K -1,525 -0.5%
Jennison Associates
10
Jennison Associates
New York
$6.55M -$425K -19,965 -7%
BFA
11
BlackRock Fund Advisors
California
$5.68M +$388K +18,246 +9%
VAM
12
Visium Asset Management
New York
$4.71M – – –
SFM
13
Sphera Funds Management
Israel
$4.24M +$3.51M +165,074 New
PI
14
Putnam Investments
Massachusetts
$4.2M – – –
State Street
15
State Street
Massachusetts
$3.94M +$524K +24,628 +19%
DCM
16
DAFNA Capital Management
California
$3.9M +$3.23M +152,002 New
Bank of Montreal
17
Bank of Montreal
Ontario, Canada
$3.36M +$2.77M +130,051 +16,056%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$3.34M +$2.09M +98,241 +309%
DMK
19
David M. Knott
$3.3M +$1.98M +93,134 +263%
BIT
20
BlackRock Institutional Trust
California
$2.94M +$194K +9,142 +9%
EA
21
Emerald Advisers
Pennsylvania
$2.8M +$2.32M +109,230 New
Northern Trust
22
Northern Trust
Illinois
$2.74M +$227K +10,669 +11%
EMFAT
23
Emerald Mutual Fund Advisers Trust
Pennsylvania
$2.62M +$2.17M +102,010 New
CAM
24
Cormorant Asset Management
Massachusetts
$2.57M – – –
PA
25
Perceptive Advisors
New York
$2.57M +$2.13M +100,000 New
1
2 3 4

ASPX Hedge Fund Activity: Q3 2014 in Review

71 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q3 2014, worth a combined $310M — up 56% from $198M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ASPX positions and 9 closed out — a net gain of 10 holders — while 34 added to existing stakes and 9 trimmed.

The largest buyer was Deerfield Management, adding an estimated $11.2M. The largest seller was Wellington Management Group, exiting entirely with an estimated $2.04M sold.

  • 71 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q3 2014, up from 61 in Q2 2014.
  • Funds reported $310M of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q3 2014, up 56% quarter-over-quarter.
  • 19 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q3 2014 and 9 closed out, a net change of +10 holders.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) buyer in Q3 2014 was Deerfield Management, an estimated $11.2M added.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q3 2014 was Wellington Management Group, an estimated $2.04M sold.

Based on aggregated 13F filings for Q3 2014.